Optimal photoperiod for indoor cultivation of leafy vegetables and herbs

In Vertical Farms with Artificial Lighting (VFALs), optimal light management is a crucial determinant of both economic and environmental viability. Applications of LED technologies to plant cultivation are still recent, and research has to date mainly targeted the definition of optimal spectral and light intensity features. On the other hand, despite the relevant implications on production costs, literature on optimal photoperiod management is to date limited. Indeed, the number of hours per day correlates with the total light supplied to the crop \u2013 expressed as Daily Light Integral (DLI) \u2013 and the associated energetic costs. The present study aims at defining how photoperiods of 16 h d-1 (DLI= 14.4 mol m-2 d-1), 20 h d-1 (DLI= 18 mol m-2 d-1) and 24 h d-1 (DLI= 21.6 mol m-2 d-1)of light affect growth performances and resource use efficiency in leafy vegetables and herbs, represented by lettuce (Lactuca sativa L.), basil (Ocimum basilicum L.), rocket (Eruca sativa Mill.), and chicory (Cichorium intybus L.). Plants were cultivated indoor under a red (R) and blue (B) LED light (RB=3, photosynthetic photon flux density (PPFD)= 250 mmol m-2 s-1). Photoperiod variations\u2019 effects differed according to the considered plant species. In lettuce and chicory, the adoption of a DLI of 14.4 mol m-2 d-1 at 16 h d-1 photoperiod resulted in a greater plants fresh biomass and leaf area, which also contributed to generally obtain higher energy use efficiency (fresh biomass per unit of electricity input), light use efficiency (dry biomass per unit of light input) and, in chicory, also water use efficiency (fresh biomass per liter of water consumed). Contrarily, although photoperiod variations did not affect basil and rocket growth parameters (e.g., fresh biomass and leaf area) and the plant capacity to transform resources (e.g., water use efficiency and light use efficiency), energy use efficiency in basil also presented a downward trend in response to growing DLI. Accordingly, the adoption of a DLI of 14.4 mol m-2 d-1 at 16 h d-1 photoperiod resulted to be the optimal option among the ones tested in the presented research

Differential host utilisation by different life history stages of the fish ectoparasite Argulus foliaceus (Crustacea: Branchiura)

Contains fulltext : 72168.pdf (publisher's version ) (Open Access

Differences between Judo, Taekwondo and Kung-fu athletes in sustained attention and impulse control

Attention processes are essential in athletic performance. Competition in combat sports requires high levels of attention, concentration and self-control. The aim of this study was to determine the differences in attention test performance among three groups of athletes from different disciplines of martial arts (judo, taekwondo and kung-fu). Twenty athletes with at least one year of experience in their respective sport were included in the study. The Test of Variables of Attention (TOVA) was performed, and data for the standard and Z scores of the quarters, halves and totals of each variable were analysed. The kung-fu athletes showed better inhibition response than the judo and taekwondo athletes. Minor performance deterioration during the impulsivity test was identified in kung-fu athletes compared with taekwondo and judo athletes. Judo athletes showed higher variability in reaction times than kung-fu athletes. Our study suggests that kung-fu training improved attention skills more than the other two disciplines. This effect can be explained by the athletes\u2019 dedication to kung-fu training and the sport\u2019s promotion of discipline, self-control and meditation

The future of religious education in Europe

This E-book is the result of a workshop on “The future of religious education in Europe”, hosted by the Robert Schuman Centre for Advanced Studies at the European University Institute in Florence on 28 October 2014.This small volume covers the entire conceptual range of approaches to religious education in public schools. The papers gathered in this publication cover the conceptual debate on the subject, ranging from a confessional approach to a sociological approach with an inclusive model as the middle-position. The different models diverge on how they define, in the context of public schooling for children aged 6 to 14 years, what religious education is aimed at: is that what should be conveyed knowledge about religion or instead religious knowledge? Should pupils become cognitively equipped to recognize and discuss religious diversity, or should they first become literate in one, presumably “their own” religious tradition?-- I Kristina Stoeckl – Knowledge about religion and religious knowledge in secular societies: introductory remarks to The future of religious education in Europe -- II Robert Jackson – Inclusive Study of Religions and other Worldviews in Publicly-funded Schools in Democratic Societies -- III Valeria Fabretti – Rethinking Religious Education sociologically: A contribution to the European debate and comparison -- IV Joachim Willems – Religious Education and the Student’s Fundamental Right to Freedom of Religion – Some Lessons and Questions from Germany -- V Matthias Scharer, Innsbruck – “Learning Religion” in the Presence of the Other: Provocation and Gift in Public Educatio

Nuclear data measurements at the upgraded neutron time-of-flight facility n-TOF at CERN

Applications of nuclear data like neutron-induced reaction cross sections are related to research fields as stellar nucleosynthesis, the study of nuclear level densities and strength functions, and also play a key role in the safety and criticality assessment of existing and future nuclear reactors, in areas concerning radiation dosimetry, medical applications, transmutation of nuclear waste, accelerator-driven systems and fuel cycle investigations. The evaluations in nuclear data libraries are based both on experimental data and theoretical models. CERN's neutron time-of-flight facility n-TOF has produced a considerable amount of experimental data since it has become fully operational with the start of its scientific measurement programme in 2002. While for a long period a single measurement station (EAR1) located at 185 m from the neutron production target was available, the construction of a second beam line at 20 m (EAR2) in 2014 has substantially increased the measurement capabilities of the facility. An outline of the experimental nuclear data activities at CERN's neutron time-of-flight facility n-TOF will be presented

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

Many clinical trials have evaluated the benefit of long-term use of antiplatelet drugs in reducing the risk of clinical thrombotic events. Aspirin and ticlopidine have been shown to be effective, but both have potentially serious adverse effects. Clopidogrel, a new thienopyridine derivative similar to ticlopidine, is an inhibitor of platelet aggregation induced by adenosine diphosphate. METHODS: CAPRIE was a randomised, blinded, international trial designed to assess the relative efficacy of clopidogrel (75 mg once daily) and aspirin (325 mg once daily) in reducing the risk of a composite outcome cluster of ischaemic stroke, myocardial infarction, or vascular death; their relative safety was also assessed. The population studied comprised subgroups of patients with atherosclerotic vascular disease manifested as either recent ischaemic stroke, recent myocardial infarction, or symptomatic peripheral arterial disease. Patients were followed for 1 to 3 years. FINDINGS: 19,185 patients, with more than 6300 in each of the clinical subgroups, were recruited over 3 years, with a mean follow-up of 1.91 years. There were 1960 first events included in the outcome cluster on which an intention-to-treat analysis showed that patients treated with clopidogrel had an annual 5.32% risk of ischaemic stroke, myocardial infarction, or vascular death compared with 5.83% with aspirin. These rates reflect a statistically significant (p = 0.043) relative-risk reduction of 8.7% in favour of clopidogrel (95% Cl 0.3-16.5). Corresponding on-treatment analysis yielded a relative-risk reduction of 9.4%. There were no major differences in terms of safety. Reported adverse experiences in the clopidogrel and aspirin groups judged to be severe included rash (0.26% vs 0.10%), diarrhoea (0.23% vs 0.11%), upper gastrointestinal discomfort (0.97% vs 1.22%), intracranial haemorrhage (0.33% vs 0.47%), and gastrointestinal haemorrhage (0.52% vs 0.72%), respectively. There were ten (0.10%) patients in the clopidogrel group with significant reductions in neutrophils (< 1.2 x 10(9)/L) and 16 (0.17%) in the aspirin group. INTERPRETATION: Long-term administration of clopidogrel to patients with atherosclerotic vascular disease is more effective than aspirin in reducing the combined risk of ischaemic stroke, myocardial infarction, or vascular death. The overall safety profile of clopidogrel is at least as good as that of medium-dose aspirin

Management of coronary disease in patients with advanced kidney disease

BACKGROUND Clinical trials that have assessed the effect of revascularization in patients with stable coronary disease have routinely excluded those with advanced chronic kidney disease. METHODS We randomly assigned 777 patients with advanced kidney disease and moderate or severe ischemia on stress testing to be treated with an initial invasive strategy consisting of coronary angiography and revascularization (if appropriate) added to medical therapy or an initial conservative strategy consisting of medical therapy alone and angiography reserved for those in whom medical therapy had failed. The primary outcome was a composite of death or nonfatal myocardial infarction. A key secondary outcome was a composite of death, nonfatal myocardial infarction, or hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest. RESULTS At a median follow-up of 2.2 years, a primary outcome event had occurred in 123 patients in the invasive-strategy group and in 129 patients in the conservative-strategy group (estimated 3-year event rate, 36.4% vs. 36.7%; adjusted hazard ratio, 1.01; 95% confidence interval [CI], 0.79 to 1.29; P=0.95). Results for the key secondary outcome were similar (38.5% vs. 39.7%; hazard ratio, 1.01; 95% CI, 0.79 to 1.29). The invasive strategy was associated with a higher incidence of stroke than the conservative strategy (hazard ratio, 3.76; 95% CI, 1.52 to 9.32; P=0.004) and with a higher incidence of death or initiation of dialysis (hazard ratio, 1.48; 95% CI, 1.04 to 2.11; P=0.03). CONCLUSIONS Among patients with stable coronary disease, advanced chronic kidney disease, and moderate or severe ischemia, we did not find evidence that an initial invasive strategy, as compared with an initial conservative strategy, reduced the risk of death or nonfatal myocardial infarction

Health status after invasive or conservative care in coronary and advanced kidney disease

BACKGROUND In the ISCHEMIA-CKD trial, the primary analysis showed no significant difference in the risk of death or myocardial infarction with initial angiography and revascularization plus guideline-based medical therapy (invasive strategy) as compared with guideline-based medical therapy alone (conservative strategy) in participants with stable ischemic heart disease, moderate or severe ischemia, and advanced chronic kidney disease (an estimated glomerular filtration rate of &lt;30 ml per minute per 1.73 m2 or receipt of dialysis). A secondary objective of the trial was to assess angina-related health status. METHODS We assessed health status with the Seattle Angina Questionnaire (SAQ) before randomization and at 1.5, 3, and 6 months and every 6 months thereafter. The primary outcome of this analysis was the SAQ Summary score (ranging from 0 to 100, with higher scores indicating less frequent angina and better function and quality of life). Mixed-effects cumulative probability models within a Bayesian framework were used to estimate the treatment effect with the invasive strategy. RESULTS Health status was assessed in 705 of 777 participants. Nearly half the participants (49%) had had no angina during the month before randomization. At 3 months, the estimated mean difference between the invasive-strategy group and the conservative-strategy group in the SAQ Summary score was 2.1 points (95% credible interval, 120.4 to 4.6), a result that favored the invasive strategy. The mean difference in score at 3 months was largest among participants with daily or weekly angina at baseline (10.1 points; 95% credible interval, 0.0 to 19.9), smaller among those with monthly angina at baseline (2.2 points; 95% credible interval, 122.0 to 6.2), and nearly absent among those without angina at baseline (0.6 points; 95% credible interval, 121.9 to 3.3). By 6 months, the between-group difference in the overall trial population was attenuated (0.5 points; 95% credible interval, 122.2 to 3.4). CONCLUSIONS Participants with stable ischemic heart disease, moderate or severe ischemia, and advanced chronic kidney disease did not have substantial or sustained benefits with regard to angina-related health status with an initially invasive strategy as compared with a conservative strategy

Health-status outcomes with invasive or conservative care in coronary disease

BACKGROUND In the ISCHEMIA trial, an invasive strategy with angiographic assessment and revascularization did not reduce clinical events among patients with stable ischemic heart disease and moderate or severe ischemia. A secondary objective of the trial was to assess angina-related health status among these patients. METHODS We assessed angina-related symptoms, function, and quality of life with the Seattle Angina Questionnaire (SAQ) at randomization, at months 1.5, 3, and 6, and every 6 months thereafter in participants who had been randomly assigned to an invasive treatment strategy (2295 participants) or a conservative strategy (2322). Mixed-effects cumulative probability models within a Bayesian framework were used to estimate differences between the treatment groups. The primary outcome of this health-status analysis was the SAQ summary score (scores range from 0 to 100, with higher scores indicating better health status). All analyses were performed in the overall population and according to baseline angina frequency. RESULTS At baseline, 35% of patients reported having no angina in the previous month. SAQ summary scores increased in both treatment groups, with increases at 3, 12, and 36 months that were 4.1 points (95% credible interval, 3.2 to 5.0), 4.2 points (95% credible interval, 3.3 to 5.1), and 2.9 points (95% credible interval, 2.2 to 3.7) higher with the invasive strategy than with the conservative strategy. Differences were larger among participants who had more frequent angina at baseline (8.5 vs. 0.1 points at 3 months and 5.3 vs. 1.2 points at 36 months among participants with daily or weekly angina as compared with no angina). CONCLUSIONS In the overall trial population with moderate or severe ischemia, which included 35% of participants without angina at baseline, patients randomly assigned to the invasive strategy had greater improvement in angina-related health status than those assigned to the conservative strategy. The modest mean differences favoring the invasive strategy in the overall group reflected minimal differences among asymptomatic patients and larger differences among patients who had had angina at baseline